4 Biotech Stocks to Keep an Eye on in 2023 The U.S. 2022 fourth-quarter GDP growth surpassed estimates and induced fresh optimism. On the other hand, the biotech industry is expected to witness robust demand despite macro uncertainties. So, given… Previous Article 3 Upgraded Stocks to Put on Your Radar This Week Next Article Diversity Is Broader Than Just Race and Gender. This Is the Often-Overlooked Piece of the Puzzle.
